Acute Promyelocytic Leukemia Approved Drugs
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Acute Promyelocytic Leukemia.
Found 1 Approved Drug for Acute Promyelocytic Leukemia
Clindamycin
Brand Names
ClindaCare, Cleocin, Xaciato, Neuac, Clindacin ETZ, Tretinion, Clindesse, Clindacin, Tretinoin, Clindamycin Phoaphate, Atralin, Twyneo, Benzaclin, Altreno, ZIANA, Tri-Luma, Vesanoid, Retin-A, Clindagel, Acanya, Renova, Onexton
Clindamycin
Brand Names
ClindaCare, Cleocin, Xaciato, Neuac, Clindacin ETZ, Tretinion, Clindesse, Clindacin, Tretinoin, Clindamycin Phoaphate, Atralin, Twyneo, Benzaclin, Altreno, ZIANA, Tri-Luma, Vesanoid, Retin-A, Clindagel, Acanya, Renova, Onexton
Form: Gel, Lotion, Injection, Suppository, Cream, Aerosol, Kit, Granule, Powder, Swab, Capsule, Solution
Method of administration: Oral, Intravenous, Intramuscular, Vaginal, Topical
FDA approval date: May 22, 1970
Classification: Lincosamide Antibacterial
TWYNEO is indicated for the topical treatment of acne vulgaris in adults and pediatric patients 9 years of age and older. TWYNEO is a combination tretinoin, a retinoid, and benzoyl peroxide indicated for the topical treatment of acne vulgaris in adults and pediatric patients 9 years of age and older. ( 1 )
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances